A sthma is one of the most common chronic illnesses of children in the United States, causing a significant health and economic burden. Morbidity from this disease results in many preventable hospital admissions and considerable use of healthcare dollars. [1] [2] [3] [4] Asthma prevalence is highest among children living in inner cities. [5] [6] [7] The development and severity of asthma is multifactorial, but ambient air pollutants are known risk factors. 8, 9 The economic burden from air pollutants and asthma is estimated to be substantial, 3 but the only previous analysis relied on expert judgment about attributable burden of disease. No epidemiologic studies have been conducted to quantify costs attributable to individual pollutants.
In the United States, air pollutant levels are regulated by the Environmental Protection Agency (EPA), which has set standards for 6 criteria pollutants, including particulate matter (PM), ozone (O 3 ), nitrogen dioxide (NO 2 ), sulfur dioxide (SO 2 ), carbon monoxide (CO), and lead. PM can be further classified into aerodynamic diameter r10 mm (PM 10 ) or r2.5 mm (PM 2.5 ).
Increasing evidence supports the association between air pollutants and asthma morbidity, including worsening asthma symptoms, [10] [11] [12] [13] increased emergency department visits, [14] [15] [16] [17] [18] and decreased lung function. [19] [20] [21] This evidence is primarily from studies of exposures in limited geographic areas, 10, 17, 20, 22, 23 although some national multicity studies exist as well. 19, [24] [25] [26] Of the 6 EPA criteria pollutants, PM 2.5 and O 3 have most often been associated with asthma morbidity. 10, 12, 13, [27] [28] [29] The existing literature on air pollutants and asthma has primarily focused on acute exposures; data regarding more chronic exposures are limited. 22, 24 In general, exposure duration of less than 14 days is acute, more than 14 days up to 1 year is subchronic, and greater than 1 year is chronic. 30 Higher chronic O 3 exposure is associated with increased risk of asthma hospitalization, 22 and higher chronic exposure to both O 3 and particulate matter is associated with increased risk of current asthma and symptom exacerbation. 24 Both subchronic and chronic PM 2.5 exposure have been associated with increased risk of hospitalization for infant bronchiolitis, another pediatric respiratory illness. 31 The objective of this exploratory study was to examine the association between subchronic exposure to air pollutants and length of stay (LOS), total charges, and total costs for pediatric asthma hospitalizations. To accomplish this, we linked 2 nationally representative datasets: the Nationwide Inpatient Sample (NIS), an annual survey of hospital discharge data, and the EPA Aerometric Information Retrieval System (AIRS), containing US air pollutant data.
The NIS allows quantification of hospitalization costs, an important step toward evaluating the economic impact made by air pollutants on pediatric asthma. Patient data in the NIS is de-identified, and the dataset contains no information on individual residence. Therefore, merging with the EPA air pollutant data occurs at the level of the hospital, not the patient. Although this is an important deficiency to consider, the NIS represents the largest dataset available to measure increases in asthma hospitalization costs associated with air pollutant levels. We, therefore, proceeded to perform descriptive, bivariate, and multivariable analysis of the 1999 to 2007 NIS to quantify the economic impact of air pollutants on pediatric asthma hospitalizations.
METHODS

Study Design
This was a multiyear cross-sectional study, including hospitalizations between 1999 and 2007 for children of age 2 to 17 years with a primary diagnosis of asthma (ICD-9 code 493.XX). Children under 2 years were excluded because wheezing at this age is often transient and diagnosis of asthma is difficult. 32 Hospitalizations with no corresponding air pollutant data were excluded. Weights accounting for sampling design were included in the NIS; these weights were incorporated into all analyses except descriptive pollutant data. Analyses were conducted using SAS-callable SUDAAN software version 10.0.1 (Research Triangle Institute, NC) to take into account the complex sampling design used by NIS. This research involved previously collected, de-identified data and was exempt from review by the Institutional Review Board of Mount Sinai School of Medicine.
Databases
The NIS is the largest all-payer inpatient care database in the United States, containing data from approximately 8 million hospitalizations annually. 33 Details with regard to sample design, data collection, and weighting are described elsewhere. 33 The survey includes diagnostic codes and basic patient demographics, and LOS and total hospital charges.
The EPA AIRS contains pollutant data recorded at defined intervals, ranging from hourly to every few days 34 ; available to the public for download. 35 We obtained text files for 6 air pollutants (PM 2.5 , PM 10 , O 3 , NO 2 , SO 2 , CO) from 1999 through 2007 to merge with the NIS hospitalization data. To assess for any systematic missing data, we compared the number of measurements available per month, day, and hour for each pollutant for each year with the total number of measurements possible; we observed no systematic patterns of missing data.
Main Outcomes: Hospitalization Data
Outcomes in this study included LOS, total charges, and total costs for pediatric asthma hospitalizations. The LOS was provided in days. Total charges represent the amount billed for each hospitalization. Charges were controlled for inflation by adjusting to 2005 dollars using the Healthcare Consumer Price Index from the Bureau of Labor. 36 Costs represent the amount of money actually paid to the hospital, generally significantly less than the charges. To estimate costs, charges were converted using hospitalspecific cost-to-charge ratio files in a dataset accompanying the NIS. These cost-to-charge ratio files are constructed using all-payer inpatient cost and charge information from the Centers for Medicare and Medicaid Services. 37 Cost-to-charge ratios were not available for data from 1999 to 2000; these years were excluded when analyzing cost. Overall, many hospitals did not have cost-to-charge ratios available, and therefore cost analyses represent only a fraction of all hospitalizations. In addition, as explained above, costs are only an estimate based on a ratio assigned to the hospital overall and not specific to the visit. The majority of our analyses were conducted to explore the nature of the relationship between pollutants and healthcare spending. For these analyses, we used charges as the outcome, allowing a greater number of hospitalizations to be included and more accuracy in our results. However, for analyses used to estimate potential healthcare savings in real healthcare dollars, we used costs as the outcome; charges as the outcome for this purpose would over-represent any potential savings.
Main Predictors: Air Pollutants
The predictors of interest were average monthly air pollutant levels. As the NIS does not contain identifying information about patient residence, air pollutant levels were determined for a defined area surrounding the hospital.
For all NIS hospitals with available addresses, we determined the latitude and longitude, which were verified using a geocoding website 38 and Google maps. The latitude and longitude for the AIRS monitors are available on a publicly available website. 39 We determined the distance between NIS hospitals and AIRS monitors using the following equation, calculating the hypotenuse of a right triangle formed by the 2 locations:
where D is distance in miles between a hospital and a monitor, lat1 and lat2 are latitudes of first and second locations, respectively, and lon1 and lon2 are longitudes of those locations.
To calculate the monthly average air pollutant levels, we averaged data from all monitors located within 10 miles of the hospital. We then linked the NIS hospital data to average monthly levels for all 6 pollutants. Two-month averages (which included the month of admission and the month before), and 3-month, 4-month, and 5-month averages were also calculated and linked to the hospital data.
Statistical Analyses
We used Spearman correlations to examine the unadjusted association between all 6 pollutants and the 3 outcomes: LOS, charges, and costs. Recognizing that pollutants arising from similar sources (eg, motor vehicles) can be highly correlated, 40, 41 we performed correlations among the pollutants to determine which ones to include in multivariable analyses. Any 2 pollutants with r Z absolute value of 0.3 were not included together in multivariable models, and we prioritized the inclusion of PM 2.5 and O 3 , the pollutants with the strongest evidence linked to adverse asthma outcomes.
Early in our analysis, we found an extremely narrow distribution of LOS among pediatric asthma hospitalizations, which are coded as ordinal numbers of days rather than hours. With the caveat that the limited distribution of LOS might make detection of pollutant effects unlikely, we used Poisson regression to account for the skewed distribution of the variable. The distribution of total charges and costs were both highly skewed. To create a normal distribution, we used the log 10 of the variables. We included air pollutants in linear regression models based on results of correlation analysis. We also included covariates associated with asthma outcomes and/or hospital charges: age, race (white, black, Hispanic, or other), sex, income, insurance (Medicare, Medicaid, private, self-pay, no charge, or other), hospital region of the country (Northeast, South, Midwest, or West), teaching status of the hospital, and month of admission. We used the median household income quartile for patient's zip code as a proxy for income.
Any pollutant found to be a significant predictor was also categorized by quartiles to examine the effects at different levels of exposure. For air pollutants found to be significant predictors, we ran stratified models for different seasons and different age groups (2 to 5 y, 6 to 12 y, 13 to 17 y). For the linear regressions, we retransformed the results from log 10 to the original scale using the smearing factor technique described by Duan. 42 The Effect of Chronicity For pollutants that were significant predictors of hospitalization charges, we examined the effect of increased exposure chronicity on outcomes. We built linear regression models with log 10 charges as the outcome and average PM 2.5 levels over differing lengths of exposure (2 to 5 mo) as the predictor in 4 separate models. The strength of the association between PM 2.5 levels of increasing duration and log 10 total charges was compared.
Appendicitis Outcomes
To validate findings between air pollutants and asthma outcomes, we ran similar multivariable models for appendicitis, a frequent cause of pediatric hospitalization that should have no association with change in air pollutant levels. We hypothesized that there would be no significant relationships found. 
RESULTS
Between 1999 and 2007, there were 70,052,217 hospital admissions in the NIS database; 206,562 were for children of age 2 to 17 years with a primary diagnosis of asthma. Hospital admissions with no corresponding air pollutant data were excluded for a final sample of 66,256 hospitalizations. Compared with all pediatric asthma hospitalizations, discharges included in the analysis had more patients who were black or Hispanic, were more likely to be in teaching hospitals, almost exclusively located in urban settings, and less likely to be located in the South (Table 1) . These findings reflect the fact that air pollutant monitors are primarily located in urban areas, where air pollutant levels are highest. Race was unreported for a large percentage of patients, as many states do not report these data to NIS. 43, 44 The mean total charges for pediatric asthma hospitalizations was $7341, with a maximum charge of $994,726. The median charges and interquartile range were $4972 and $5227, respectively. The mean total cost was $3235, with a maximum cost of $441,001. The median costs and interquartile range were $2338 and $2147, respectively. The descriptive data for air pollutant levels are shown in Table 2 , including the current EPA criteria.
In unadjusted analyses, all 6 pollutants had minimal correlation with the 3 outcomes: LOS, total charges, and total costs (r<0.1 and P<0.001 for all analyses). In regards to correlations among the different pollutants, PM 2.5 and PM 10 were most highly correlated with each other (r = 0.5). SO 2 and CO were negatively correlated with O 3 (r = À 0.4), and PM 2.5 and CO were positively correlated (r = 0.4). As mentioned above, we prioritized PM 2.5 and O 3 for inclusion in final models because of known relationships with asthma morbidity. Therefore, PM 2.5 , O 3 , and NO 2 were further examined in 3-pollutant multivariable analyses.
In multivariable analyses, none of the 3 pollutants were significant predictors of LOS (Table 3) . However, PM 2.5 remained a significant predictor of both charges and costs. When the model for costs was run with PM 2.5 as a variable categorized by quartile, the lowest quartile of exposure led to an average decrease of $918 (95% CI, +$559 to +$1105) in costs compared with the highest quartile of exposure. Stratified models examining PM 2.5 and total charges showed evidence of effect modification by season and age (Table 4) . The relationship was strongest in the summer and weakest in the winter. The oldest age group had the strongest association between PM 2.5 and charges (+$240; 95% CI, +$ 29 to +$658).
The Effect of Chronicity
When increasing durations of PM 2.5 exposure were used as the predictor in the linear regression model for asthma total charges, the relationship between PM 2.5 and yNot to be exceeded more than once per year on average over 3 y. JTo attain this standard, the 3-year average of the fourth-highest daily maximum 8-hour average ozone concentrations measured at each monitor within an area over each year must not exceed 0.075 ppm (effective May 27, 2008) .
zThe standard is attained when the expected number of days per calendar year with maximum hourly average concentrations above 0.12 ppm is r1. #To attain this standard, the 3-year average of the 98th percentile of the daily maximum 1-hour average at each monitor within an area must not exceed 0.1 ppm or 100 ppb (effective January 22, 2010). **Not to be exceeded more than once per year. wwTo attain this standard, the 3-year average of the 99th percentile of the daily maximum 1-hour average at each monitor within an area must not exceed 0.075 ppm or 75 ppb (effective June 2, 2010).
PM 10 indicates particulate matter of diameter <10 mm; PM 2.5 , particulate matter of diameter <2.5 mm; ppm, parts per million.
charges continued to become stronger and more significant, with average PM 2.5 during the 5 months preceding hospitalization having the strongest association (+$222; 95% CI, +$100 to +$404; Fig. 1 ).
Appendicitis Outcomes
Linear regression models with the outcomes of total charges and costs for appendicitis hospitalizations, including the same predictors as in the other models, did not show a significant association with PM 2.5 . Although some variables were significant predictors, showing the potential variability in appendicitis charges, PM 2.5 was not significantly associated with the outcome, contrary to the findings with asthma hospitalizations.
DISCUSSION
In this national study, we found a significant association between average PM 2.5 levels around hospitals and pediatric asthma hospitalization total charges and costs, but not LOS. The relationship was found to be the strongest in the summer and among older children. The association was stronger with an increasing chronicity of exposure. We found no association between PM 2.5 and appendicitis outcomes.
Substantial health care dollars are spent each year on asthma, 1, 3 and controlling levels of PM 2.5 may result in considerable savings. We found that a 1-unit increase in PM 2.5 increased pediatric asthma hospitalization costs on average by $47. There are approximately 200,000 pediatric asthma hospitalizations in the United States annually, about 85% of which are in urban areas. 45 Extrapolating our findings to all urban pediatric asthma hospitalizations, reducing the average level of PM 2.5 by 1 unit could save about $8 million annually. We also found that decreasing PM 2.5 from the highest to lowest quartile decreased costs on average by $918 per hospitalization. Extrapolating this to the 25% of urban hospitals in the highest quartile, decreasing PM 2.5 to the lowest quartile could save about $39 million. This amount represents only a small fraction of potential healthcare savings resulting from reduced PM 2.5 levels, especially given other well-known adverse health outcomes associated with this pollutant, such as cardiac mortality. 46, 47 These figures are also conservative as they represent total costs, not charges.
Interestingly, increased charges were not found with other air pollutants, such as O 3 , known to have adverse effects on asthma outcomes. One explanation is that, as shown in previous studies, ambient O 3 levels measured at central monitoring sites may not be representative of personal exposure, in contrast to PM 2.5 for which ambient levels are highly correlated with personal exposure. [48] [49] [50] Inaccurate represention of personal exposure biases the results toward the null; perhaps this is why no relationship is seen with other pollutants. Another potential explanation is that the effects of subchronic exposure to O 3 are different than acute exposure. Although the acute effects of O 3 on asthma are well known, subchronic exposure to O 3 may not play a significant role in adverse asthma outcomes, at least not enough to translate into increased hospitalization costs and charges.
We hypothesized that higher PM 2.5 levels lead to increased asthma severity and thus increased charges, in part mediated by increased LOS. However, we found no zIncrement change in dollars calculated using Duan transformation for linear regression. *P value r0.1. **P value r0.001. ***P value r0.0001. avg indicates average; CI, confidence interval; PM 2.5 , particulate matter of diameter <2.5 mm. significant association with LOS. As LOS is measured in units of whole days, it would take quite a significant increase in severity to result in another full day of hospitalization and as mentioned above, the narrow distribution of LOS limited our analytic capacity. The associations between charges and PM 2.5 showed effect modification by season and age, with results most significant for summer months and older children. Previous studies have shown that ambient PM 2.5 concentrations are most highly correlated to personal exposure during summer months when people spend most of the time outdoors. 48 Older children also tend to spend more time outdoors. In both cases, the stronger associations found may be because personal exposure is being more closely approximated by ambient PM 2.5 levels during warmer months and in older children. Although asthma severity and overall hospitalization charges may be highest in the winter, PM 2.5 levels may not be as strongly associated with charges because children have relatively lower exposure compared with warmer seasons.
There is little known about subchronic effects of PM 2.5 on asthma outcomes. We found that the chronicity of PM 2.5 exposure played an important role in the association with costs and charges: an increasing duration of exposure showed stronger and more significant associations. That is, long-term exposure to PM 2.5 had more of an effect than short-term exposure. These results are supported by a recent study showing that children with higher exposure to PM 2.5 for 1 year were more likely to be diagnosed with asthma and have asthma attacks. 24 One plausible explanation is that similar to its role in cardiac mortality, 46 PM 2.5 leads to increased inflammation over time and consequently increased severity when children have asthma attacks. Our findings raise some interesting questions and highlight the importance of continued research into the associations between subchronic PM 2.5 exposure and asthma morbidity.
An important limitation of this study is that the exposure measurement is crude. We have used ambient pollutant concentrations near the hospitals because information about personal exposures is unavailable. Earlier studies have shown that ambient PM 2.5 levels measured at central monitoring sites are highly correlated with average personal PM 2.5 exposure. 48 In contrast, ambient O 3 , NO 2 , and SO 2 concentrations are weakly correlated with personal exposures to these gases. [48] [49] [50] This supports the fact that our PM 2.5 exposure measure represents personal exposure fairly accurately, provided that the majority of patients live in the vicinity of the hospital. There are inevitably some incorrect exposure assessments; however, these misclassifications would tend to bias the results towards the null, and we found clear and consistent relationships with PM 2.5 in spite of these misclassifications. The lack of association with the other pollutants may be due to incorrect exposure assessment. An alternate explanation, as mentioned above, is that subchronic exposure to the other pollutants may not play a role in asthma severity.
It is important to note that all 4 regions of the country were not equally represented. Overall, the South represented 38% of all hospitalizations but only 6% of included hospitalizations. As fewer hospitalizations in the South occur in urban areas (75%) compared with other regions (Z85%), a greater proportion did not have corresponding pollutant data, limiting the sample of Southern hospitalizations compared with other regions. Correspondingly, the Northeast and West are overrepresented in our analyses.
Another limitation is that the NIS does not contain details with regard to management during hospitalization, for example, medications used and intensive care. As discussed above, the proposed mechanism of the association is increased asthma severity resulting in increased use of hospital resources. Without detailed information about hospital stays, we are unable to examine the specific etiologies of the increased charges.
An additional potential limitation is residual confounding by socioeconomic status. It is known that asthma severity is worse in urban, inner-city areas, which are also the areas where PM 2.5 levels tend to be the highest. In multivariable analyses, we did our best to control for income and insurance as markers of socioeconomic status. In addition, urban areas are where other air pollutant levels are highest, and no associations were found with pollutants besides PM 2.5 . The clear and consistent associations found between increasing durations of PM 2.5 and hospital charges make it likely that the relationships seen are specific to PM 2.5 and not due to confounding by socioeconomic status.
A major strength is that our results are based on a large amount of data nationally representative of urban area hospitals. Although these results cannot be translated to nonurban areas, as stated above, 85% of pediatric asthma hospitalizations do occur in urban areas. 45 Another important strength is that secondary analysis examining the relationship between PM 2.5 and appendicitis hospitalization charges showed no significant association, validating our results that the association is for a diagnosis with a biologically plausible connection with PM 2.5 and not a spurious finding. We also have results in costs, not just charges. It is a strength that our study provides results in actual healthcare dollars spent. Our results should be interpreted with caution because the exposure assessment is inherently with limitations. Other studies have used more complex methods to assess personal exposure to air pollutants, such as modeling multiple point source data into an aggregate exposure metric. However, no other studies have examined healthcare costs associated with specific air pollutants or the health effects of subchronic air pollutant exposure on pediatric asthmaF2 important areas of future research. Despite the deficiencies noted, our findings merit further study using more rigorous exposure assessment and datasets containing detailed information with regard to healthcare utilization. Subchronic PM 2.5 exposure is associated with increased costs for pediatric asthma hospitalizations. Studies, such as this one, should stimulate further research in this area and incite regulatory agencies, such as the EPA, to consider subchronic pollutant levels when setting standards for air pollutants. Our results provide economic data to reinforce the need for ongoing efforts to reduce levels of air pollutants in this country. Policy changes to improve air quality may lead to improved asthma outcomes and substantial savings in healthcare spending.
